Marvell Buyout Offer Creates Arbitrage Gap as Lumentum Trades Below Deal Price Amid Regulatory Uncertainty

What happened

Marvell has made a buyout offer for Lumentum, and Lumentum's stock is trading below the offer price, creating a merger arbitrage opportunity. Lumentum's revenue is more than doubling year-over-year, driven by AI datacenter demand, but its stock now tracks Marvell's shares and the regulatory review timeline that could extend to 2028. The master report from August flagged significant risks, including customer concentration with one customer at 26.6% of revenue and structural pricing pressure in cloud transceivers. While a buyout could cap downside at the offer price, the deal's long regulatory path introduces uncertainty, and if the deal fails, the stock could revert to fundamental valuation around $860 or lower. Investors must weigh the probability of deal completion against the underlying business's cyclical risks.

Implication

For merger arbitrageurs, the spread between current price and offer price may offer a return if the deal closes, but the 2028 regulatory horizon means capital is locked for years. The deal's completion hinges on regulatory approvals that could face hurdles given concentration in the optical networking supply chain. If the deal fails, Lumentum's fundamentals remain strong but its valuation was already stretched at $870 with no margin of safety per the master report. Investors should monitor Marvell's financial health and any signs of deal financing or antitrust concerns. A prudent approach may be to wait for clearer regulatory signals before committing, as the downside in a broken deal scenario could be significant given the stock's recent run-up.

Thesis delta

Original thesis was WAIT based on rich valuation and concentration risks. The Marvell buyout offer introduces a new variable: a potential exit at a premium, but with a long regulatory runway. The thesis shifts from 'wait for better entry' to 'evaluate deal probability and arbitrage spread', but the fundamental risks remain if the deal collapses.